American not-for-profit organisation The Society of Thoracic Surgeons (STS) has introduced the STS Risk Calculator App, a mobile application designed to provide real-time access to its range of adult cardiac surgery and thoracic surgery risk calculators.

Intended for surgeons and multidisciplinary medical professionals, the app draws on data from the STS National Database and can be accessed via iOS and Android platforms.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This database is a resource containing around ten million cardiothoracic procedures carried out by more than 4,300 surgeons, utilising the same statistical models found in STS’ online risk calculators.

The STS Risk Calculator App is designed to be intuitive and user-friendly, allowing for quick risk evaluations at the bedside or while on the move.

This real-time access to data is pivotal in supporting informed clinical decisions and enhancing the quality of care delivered to individuals.

The app includes individualised risk assessments for cardiac procedures such as isolated tricuspid valve repair and replacement, and multi-valve surgery with or without coronary artery bypass grafting.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

It also predicts outcomes such as stroke, death, renal failure, and hospital stay periods.

STS president Joseph Sabik III said: “Having immediate access to reliable, evidence-based risk assessment tools is critical for improving surgical decision-making and patient outcomes.

“This mobile application ensures that up-to-date, risk-adjusted data is always within reach, bringing the power of the STS National Database to surgeons and care teams wherever and whenever they need it.”

STS noted that the Esophagectomy Risk Calculator offers 30-day risk evaluations for oesophageal cancer patients while the Lung Cancer Resection Risk Calculator will estimate 30-day postoperative risks for lung cancer resection procedures, including segmentectomy, lobectomy, or wedge resection.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact